Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- PMDA to Increase Staff with Academic Background in Natural Sciences
November 3, 2008
- Korosho to Optimize Approved Doses for 4 Thiazide Diuretics
November 3, 2008
- NEW PRODUCTS
November 3, 2008
- Stronger Incentives Needed to Promote Use of Generics: Mr Sawai
October 27, 2008
- Korosho to Review Doses of Thiazide Diuretics Approved in Japan
October 27, 2008
- Japan-India EPA Negotiations Tangled over Review of Indian Generics
October 27, 2008
- Pharmacies Should Proactively Participate in Home Medical Care: Mr Kishida
October 27, 2008
- Korosho to Revise Criterion for Payment of Premium for Dispensing Generics
October 27, 2008
- 20% of Professors Think Decision Making May Be Biased by Donations
October 27, 2008
- GENERICS NEWS IN BRIEF
October 27, 2008
- Only 11 Centers to Treat Cognitive Disorders Established to Date
October 27, 2008
- Bio Japan 2008
October 27, 2008
- BP Levels, Hypotensive Targets at Initiation of Treatment Dropping: CareNet Survey
October 27, 2008
- NEW PRODUCTS
October 27, 2008
- AZ Strengthens Its Biopharmaceuticals R&D Pipeline: Mr Brennan
October 27, 2008
- Kitasato Univ.-Harvard School of Public Health Symposium
October 27, 2008
- R&D NEWS IN BRIEF
October 27, 2008
- Sports Improve Symptoms of Schizophrenia
October 27, 2008
- Korosho to Ally with Authorities from Other Countries to Eliminate Drug Lag
October 27, 2008
- Merck Serono, Bristol-Myers to Copromote Erbitux with 300 MRs
October 27, 2008
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…